Document is current

Any future updates will be listed below

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

Crossref DOI link: https://doi.org/10.1038/s41392-023-01317-7

Published Online: 2023-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark